Free Trial

Inogen (INGN) News Today

Inogen logo
$6.53 -0.22 (-3.26%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$6.52 -0.01 (-0.15%)
As of 05/23/2025 06:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

INGN Latest News

Inogen, Inc. stock logo
Inogen (NASDAQ:INGN) Stock Rating Upgraded by Needham & Company LLC
Needham & Company LLC raised shares of Inogen from a "hold" rating to a "buy" rating and set a $12.00 price target on the stock in a research note on Thursday.
Needham Upgrades Inogen (INGN) to Buy
Needham Upgrades Inogen (INGN)
Needham Upgrades Inogen (INGN) to Buy
Inogen, Inc. stock logo
Cubist Systematic Strategies LLC Raises Stock Position in Inogen, Inc. (NASDAQ:INGN)
Cubist Systematic Strategies LLC boosted its position in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 109.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 123,242 shares of the
Inogen, Inc. stock logo
Dimensional Fund Advisors LP Buys 123,208 Shares of Inogen, Inc. (NASDAQ:INGN)
Dimensional Fund Advisors LP boosted its stake in Inogen, Inc. (NASDAQ:INGN - Free Report) by 25.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 607,837 shares of the medical technology company's stock after
Inogen, Inc. stock logo
Fred Alger Management LLC Has $5.51 Million Holdings in Inogen, Inc. (NASDAQ:INGN)
Fred Alger Management LLC trimmed its stake in Inogen, Inc. (NASDAQ:INGN - Free Report) by 15.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 600,995 shares of the medical technology company's stock after selling 111,847 shares d
Inogen, Inc. stock logo
Inogen, Inc. (NASDAQ:INGN) Shares Sold by Divisadero Street Capital Management LP
Divisadero Street Capital Management LP cut its position in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 81.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 200,000 shares of the medical technology company's stock af
Q1 2025 Inogen Inc Earnings Call Transcript
Inogen, Inc. stock logo
Inogen (INGN) Expected to Announce Earnings on Wednesday
Inogen (NASDAQ:INGN) will be releasing its Q1 2025 earnings after the market closes on Wednesday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-7-inogen-inc-stock/)
Inogen, Inc. stock logo
Short Interest in Inogen, Inc. (NASDAQ:INGN) Decreases By 16.1%
Inogen, Inc. (NASDAQ:INGN - Get Free Report) saw a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 662,900 shares, a decline of 16.1% from the March 15th total of 790,000 shares. Approximately 2.8% of the shares of the company are sold short. Based on an average daily trading volume, of 336,200 shares, the short-interest ratio is presently 2.0 days.
Inogen, Inc. stock logo
Inogen, Inc. (NASDAQ:INGN) Shares Acquired by Renaissance Technologies LLC
Renaissance Technologies LLC increased its stake in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 17.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 492,900 shares of the medical technology c
Inogen, Inc. stock logo
JPMorgan Chase & Co. Lowers Stock Position in Inogen, Inc. (NASDAQ:INGN)
JPMorgan Chase & Co. trimmed its holdings in Inogen, Inc. (NASDAQ:INGN - Free Report) by 30.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 627,030 shares of the medical technology company's stock after selling 269,
Inogen, Inc. stock logo
Federated Hermes Inc. Raises Stock Holdings in Inogen, Inc. (NASDAQ:INGN)
Federated Hermes Inc. raised its position in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 16.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 404,273 shares of the medical technology company's stock after purchasing an additiona
Inogen, Inc. stock logo
Trexquant Investment LP Has $1.16 Million Stock Holdings in Inogen, Inc. (NASDAQ:INGN)
Trexquant Investment LP raised its position in Inogen, Inc. (NASDAQ:INGN - Free Report) by 137.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 125,930 shares of the medical tech
Inogen, Inc. stock logo
Arrowstreet Capital Limited Partnership Boosts Stock Position in Inogen, Inc. (NASDAQ:INGN)
Arrowstreet Capital Limited Partnership lifted its holdings in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 154.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 263,561 shares of the medical tech
Inogen, Inc. stock logo
Needham & Company LLC Reiterates "Hold" Rating for Inogen (NASDAQ:INGN)
Needham & Company LLC reaffirmed a "hold" rating on shares of Inogen in a research report on Wednesday.
Needham Sticks to Their Hold Rating for Inogen (INGN)
Inogen, Inc. stock logo
Prudential Financial Inc. Grows Stock Holdings in Inogen, Inc. (NASDAQ:INGN)
Prudential Financial Inc. lifted its position in Inogen, Inc. (NASDAQ:INGN - Free Report) by 141.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 360,002 shares of the medical technology company's stock afte
Inogen, Inc. stock logo
Stokes Family Office LLC Has $1.50 Million Stock Holdings in Inogen, Inc. (NASDAQ:INGN)
Stokes Family Office LLC grew its position in Inogen, Inc. (NASDAQ:INGN - Free Report) by 29.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 163,500 shares of the medical technology company's stock after purchasing an additional 36,715
Inogen, Inc. stock logo
Royce & Associates LP Increases Stock Holdings in Inogen, Inc. (NASDAQ:INGN)
Royce & Associates LP raised its stake in Inogen, Inc. (NASDAQ:INGN - Free Report) by 499.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 311,199 shares of the medical technology company's stock after purchasing a
Inogen, Inc. stock logo
Connor Clark & Lunn Investment Management Ltd. Grows Holdings in Inogen, Inc. (NASDAQ:INGN)
Connor Clark & Lunn Investment Management Ltd. lifted its position in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 42.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 248,822 s
Inogen, Inc. stock logo
Monaco Asset Management SAM Buys 39,000 Shares of Inogen, Inc. (NASDAQ:INGN)
Monaco Asset Management SAM increased its holdings in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 104.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 76,500 shares of the medical technology company's stock after pu
Inogen, Inc. stock logo
Inogen, Inc. (NASDAQ:INGN) Short Interest Update
Inogen, Inc. (NASDAQ:INGN - Get Free Report) was the target of a large decrease in short interest during the month of February. As of February 15th, there was short interest totalling 665,900 shares, a decrease of 16.6% from the January 31st total of 798,600 shares. Based on an average daily trading volume, of 246,200 shares, the short-interest ratio is presently 2.7 days. Approximately 3.2% of the shares of the company are short sold.
Inogen, Inc. stock logo
Inogen (NASDAQ:INGN) Stock Rating Lowered by StockNews.com
StockNews.com downgraded Inogen from a "buy" rating to a "hold" rating in a report on Wednesday.
Inogen, Inc. stock logo
Inogen (NASDAQ:INGN) Posts Earnings Results, Beats Expectations By $0.15 EPS
Inogen (NASDAQ:INGN - Get Free Report) posted its earnings results on Tuesday. The medical technology company reported ($0.41) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.56) by $0.15. Inogen had a negative return on equity of 27.38% and a negative net margin of 15.89%.
Get Inogen News Delivered to You Automatically

Sign up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter.

INGN Media Mentions By Week

INGN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

INGN
News Sentiment

0.67

0.75

Average
Medical
News Sentiment

INGN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

INGN Articles
This Week

10

2

INGN Articles
Average Week

Get Inogen News Delivered to You Automatically

Sign up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:INGN) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners